How competing risks affect the epidemiological relationship between vitamin D and prostate cancer incidence? A population-based study.

Abstract

We hypothesized that controversial results regarding the epidemiological relationship between circulating 25-hydroxyvitamin D, 25(OH)D, and risk of prostate cancer (PCA) incidence are partly due to competing risks. To test the hypothesis, we studied associations across 25(OH)D, PCA and death in 2578 middle-aged men belonging to the Kuopio Ischaemic Heart Disease Risk Factor Study. The men were free of cancer at baseline, and the mean (SD) follow-up time was 23.3 (9.1) years. During this period, 296 men had a PCA diagnosis, and 1448 men died without the PCA diagnosis. The absolute risk of developing PCA was highest in the highest 25(OH)D tertile (15%), whereas that of death was highest in the lowest 25(OH)D tertile (67%). A competing risk analysis showed that belonging to the highest 25(OH)D tertile increased the risk of PCA incidence and improved survival with the respective hazard ratios (HR) of 1.35 (95% CI = 1.07-1.70) and 0.79 (95% CI = 0.71-0.89). Adjusting for 10 covariates together with 25(OH)D did not significantly change the results, but the respective adjusted HRs for PCA and death were 1.20 and 0.87. To conclude, the competing risk analysis did not eliminate the direct relationship between 25(OH)D and PCA but rather strengthened it.

• Authors: Ari Voutilainen, Jyrki K Virtanen, Sari Hantunen, Tarja Nurmi, Petra Kokko, Tomi-Pekka Tuomainen
• Journal: Andrologia (Andrologia) Vol. 54 Issue 6 Pg. e14410 (Jul 2022) ISSN: 1439-0272 [Electronic] Germany
• PMID: 35229338 (Publication Type: Journal Article)
• Copyright: © 2022 The Authors. Andrologia published by Wiley-VCH GmbH.

Chemical References

• Vitamins
• Vitamin D

Topics

• Humans
• Incidence
• Male
• Middle Aged
• Prospective Studies
• Prostatic Neoplasms (epidemiology, etiology)
• Risk Factors
• Vitamin D
• Vitamins